Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$17.3B
sum of reported positions
Reported positions
354
Changes vs prior quarter
395
84 new · 85 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 396 measured positions in 8 quarters, the typical new or larger position finished −3.9 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 985K | $470M | 2.7% | |
| 6.85M | $322M | 1.9% | |
| 959K | $321M | 1.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $13.6B | $17.3B |
| Positions | 355 | 354 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 3% |
| 4.42M |
| $267M |
| 1.5% |
| 786K | $262M | 1.5% |
| 2.8M | $249M | 1.4% |
Crinetics Pharmaceuticals Inc | 6.46M | $242M | 1.4% |
Apogee Therapeutics Inc | 1.74M | $231M | 1.3% |
| 1.53M | $230M | 1.3% |
| 6.72M | $223M | 1.3% |
| 557K | $217M | 1.3% |
| 4.73M | $192M | 1.1% |
| 497K | $189M | 1.1% |
| 1.31M | $187M | 1.1% |
| 229K | $174M | 1.0% |
| 1.77M | $171M | 1.0% |
| 6.16M | $152M | 0.9% |
| 4.43M | $148M | 0.9% |
| 1.21M | $144M | 0.8% |
| 1.56M | $142M | 0.8% |
| 517K | $141M | 0.8% |
| 227K | $140M | 0.8% |
| 4.83M | $140M | 0.8% |
| 1.99M | $138M | 0.8% |
| 355K | $134M | 0.8% |
Crane (CR)
253K → 77K shares (−70%)
Sionna Therapeutics (SION)
77K → 385K shares (+403%)
Applied Digital (APLD)
450K shares
Incyte (INCY)
128K → 148K shares (+16%)
Revolution Medicines (RVMD)
89K shares
Methode Electronics (MEI)
853K shares
Hut 8 (HUT)
210K → 140K shares (−34%)
Elanco (ELAN)
344K → 651K shares (+89%)
Alcoa (AA)
296K shares
Nexgen Energy (NXE)
3.77M → 1.64M shares (−57%)
Innventure Inc
2.99M shares
Rhythm Pharmaceuticals (RYTM)
437K → 129K shares (−70%)
SolarEdge (SEDG)
240K shares
Intercorp Financial Services (IFS)
297K → 245K shares (−18%)
Allison Transmission (ALSN)
219K → 123K shares (−44%)
Five Below (FIVE)
157K → 75K shares (−52%)
BWX Technologies (BWXT)
137K → 68K shares (−50%)
Precision Drilling (PDS)
168K shares
Alnylam Pharmaceuticals (ALNY)
60K → 43K shares (−28%)
Innio (INIO)
317K shares
Alx Oncology (ALXO)
5.73M → 6.03M shares (+5%)
Guardian Metal Resources (GMTL)
555K → 860K shares (+55%)
Iamgold (IAG)
3.25M → 741K shares (−77%)
Voyager Technologies, Inc. (VOYG)
364K shares
United States Antimony (UAMY)
5.35M → 1.61M shares (−70%)
